FDA Says Antiepilepsy Drugs Topamax and Depakote Cause Birth Defects

It is a confirmed fact that women with epilepsy comprise one-half of a percent of all pregnancies in America. These women are often treated with the antiepilepsy drugs such as Topamax or Depakote.

The highest doses of Depakote (1500 mg per day or greater) and phenobarbital (150 mg per day or day or greater) pose the highest risk of birth defects. Another disturbing statistic is that if a parent history of major birth defects is in place in addition to taking these epilepsy drugs, the risk of birth defects is four times greater.

The Food and Drug Administration (FDA) has also weighed in that Topamax triples the risk of cleft palate and other birth defects of the oral cavity when taken during the first trimester of pregnancy compared with other anti-epilepsy drugs.

If you or someone you know has taken Topamax or Depakote and given birth to a child with birth defects, please contact me directly for a free, no-obligation evaluation of your claim.

About the Firm: The Michael Brady Lynch Firm is a trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects such as Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, as well as Actos Bladder Cancer and Fosamax Femur Fractures, and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving these products.

Leave a Reply

Your email address will not be published. Required fields are marked *

Contact Us Today

Contact our lawyers directly through the email form below.





Type of Case

How did you find out about us?

×